| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 58.80▼ | 59.05▼ | 59.05▼ | 55.85▼ | 57.44▼ |
| MA10 | 59.33▼ | 59.88▼ | 59.88▼ | 56.67▼ | 59.94▼ |
| MA20 | 60.42▼ | 61.04▼ | 61.04▼ | 58.12▼ | 60.95▼ |
| MA50 | 61.92▼ | 62.13▼ | 62.09▼ | 60.80▼ | 60.46▼ |
| MA100 | 60.74▼ | 60.06▼ | N/A | 61.41▼ | 57.96▼ |
| MA200 | N/A | N/A | N/A | 61.78▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.238▼ | -0.395▼ | -0.404▼ | -0.197▼ | -0.999▼ |
| RSI | 31.867▼ | 33.973▼ | 34.275▼ | 35.347▼ | 31.510▼ |
| STOCH | 16.898▼ | 14.433▼ | 14.433▼ | 22.863 | 25.871 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ |
| CCI | -172.406▼ | -138.305▼ | -138.305▼ | -137.478▼ | -168.206▼ |
|
Monday, March 16, 2026 09:01 AM
Registration link below for Wednesday March 18, 2026 at 4 PM EDT Phio invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to ...
|
|
Sunday, February 22, 2026 04:00 PM
Phase 1b Trial Reported Approximately 65% Pathological Response in cSCC, Including Complete Responses at Maximum Dose, With No Serious Adverse Events Phio Pharmaceuticals Corp. (NASDAQ:PHIO) NEW YORK, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/03/26 | 55.665 | 55.665 | 54.7787 | 54.7787 | 996 |
| 25/03/26 | 56.73 | 57.15 | 56.7248 | 56.7248 | 1,194 |
| 24/03/26 | 56.01 | 56.27 | 55.918 | 56.0607 | 2,415 |
| 23/03/26 | 56.72 | 56.8219 | 56.64 | 56.8219 | 1,429 |
| 20/03/26 | 56.47 | 56.47 | 54.8854 | 54.8854 | 603 |
| 19/03/26 | 56.38 | 56.951 | 56.19 | 56.951 | 2,911 |
| 18/03/26 | 58.25 | 58.25 | 57.342 | 57.342 | 1,100 |
| 17/03/26 | 58.50 | 58.50 | 58.27 | 58.27 | 1,084 |
| 16/03/26 | 58.85 | 58.85 | 57.80 | 58.1982 | 2,247 |
| 13/03/26 | 57.73 | 57.73 | 56.6208 | 56.6208 | 448 |
|
|
||||
|
|
||||
|
|